THINK Surgical
Private Company
Total funding raised: $234M
Overview
THINK Surgical is a pioneer in orthopedic robotics, having been founded in 2000. The company's flagship product, the TSolution One® Total Knee Application, combines 3D pre-operative planning software (TCAT®) with an open-platform robotic execution system (TCure®). This approach allows surgeons to create a personalized surgical plan pre-operatively, which is then executed with robotic precision. As a private company, it operates in the competitive but high-growth market of robotic-assisted orthopedic surgery, leveraging AI and machine learning to differentiate its platform.
Technology Platform
The TSolution One® platform integrates AI-driven pre-operative planning software (TCAT®) with an active, open-architecture robotic surgical system (TCure®) for precise bone preparation in joint replacement surgeries.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
THINK Surgical competes in the active robotic surgery segment for orthopedics against dominant players like Stryker (Mako), Zimmer Biomet (ROSA), and Johnson & Johnson (VELYS). These competitors typically offer closed, proprietary platforms tied to their own implant portfolios. THINK's primary differentiation is its open-platform architecture and its strong emphasis on AI-assisted pre-operative planning, aiming to offer greater surgeon flexibility and data-driven precision.